EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Glycyrrhetinic acid blocks SARS‐CoV‐2 infection by activating the cGAS‐STING signalling pathway

Hui Qi iD, Qin-Hai Ma, Wei Feng, Si-Mian Chen, Cai-Sheng Wu, Yanan Wang, Tong-Xing Wang, Yun-Long Hou, Zhen-Hua Jia

British Journal of Pharmacology · 2024-10 · 181 (20) · 3976-3992

DOI: 10.1111/bph.16473 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Pharmacology, online erschienen am 23.06.2024. Verfasst von Hui Qi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Hebei Academy of Integrated Traditional Chinese and Western Medicine, Shijiazhuang, Hebei, China. Hauptthemen laut MEDLINE: Signal Transduction, Membrane Proteins, Glycyrrhetinic Acid, SARS-CoV-2. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Innovation Team and Talents Cultivation Program of National Administration of Traditional Chinese Medicine, S&T Program of Hebei, National Natural Science Foundation for Youth Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Purpose Traditional Chinese medicine (TCM) played an important role in controlling the COVID‐19 pandemic, but the scientific basis and its active ingredients are still weakly studied. This study aims to decipher the underlying anti‐SARS‐CoV‐2 mechanisms of glycyrrhetinic acid (GA). Experimental Approach GA's anti‐SARS‐CoV‐2 effect was verified both in vitro and in vivo. Homogeneous time‐resolved fluorescence assays, biolayer interferometry technology, and molecular docking were employed to examine interactions of GA with human stimulator of interferon genes (hSTING). Immunofluorescence staining, western blot, and RT‐qPCR were used to investigate nuclear translocation of interferon regulatory factor 3 (IRF3) and levels of STING target genes. Pharmacokinetics of GA was studied in mice. Key Results GA could directly bind to Ser162 and Tyr240 residues of hSTING, thus up‐regulating downstream targets and activation of the STING signalling pathway. Such activation is crucial for limiting the replication of SARS‐CoV‐2 Omicron in Calu‐3 cells and protecting against lung injury induced by SARS‐CoV‐2 Omicron infection in K18‐ACE2 transgenic mice. Immunofluorescence staining and western blot indicated that GA increased levels of phosphorylated STING, phosphorylated TANK‐binding kinase‐1, and cyclic GMP‐AMP synthase (cGAS). Importantly, GA increased nuclear translocation of IRF3. Pharmacokinetic analysis of GA in mice indicated it can be absorbed into circulation and detected in the lung at a stable level. Conclusion and Implications Activation of the cGAS‐STING pathway through the GA‐STING‐IRF3 axis is essential for the antiviral activity of GA in mice, providing new insights into the potential translation of GA for treating SARS‐CoV‐2 in patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Signal TransductionMembrane ProteinsGlycyrrhetinic AcidSARS-CoV-2NucleotidyltransferasesCOVID-19Interferon Regulatory Factor-3COVID-19 Drug TreatmentAntiviral AgentsAnimalsHumansMiceMaleMolecular Docking SimulationSTING ProteinCyclic Guanosine Monophosphate-Adenosine Monophosphate Synthase

Stichwörter der Autor:innen

3CL‐proACE2COVID‐19cGAS‐STINGglycyrrhetinic acidmolecular docking

Substanzen

Membrane ProteinsGlycyrrhetinic AcidNucleotidyltransferasesInterferon Regulatory Factor-3Antiviral AgentsSTING1 protein, humanSTING ProteinSting1 protein, mousecGAS protein, humanCyclic Guanosine Monophosphate-Adenosine Monophosphate Synthase

Autor:innen und Institutionen

  • Hebei Academy of Integrated Traditional Chinese and Western Medicine, Shijiazhuang, Hebei, China.
  • State Key Laboratory for Innovation and Transformation of Luobing Theory, Shijiazhuang, China.
  • New Drug Evaluation Center, Shijiazhuang Yiling Pharmaceutical Co., Ltd, Shijiazhuang, Hebei, China.
  • State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou…
  • Fujian Provincial Key Laboratory of Innovative Drug Target Research and State Key Laboratory of Cellular Stress Biology, School of Pharmaceutical Sciences, Xiamen University, Xiamen, China.

ORCID-Profile: Hui Qi

Förderung

  • Innovation Team and Talents Cultivation Program of National Administration of Traditional Chinese Medicine
  • S&T Program of Hebei
  • National Natural Science Foundation for Youth Project
  • National Natural Science Foundation of China
  • Natural Science Foundation of Hebei Province
  • Natural Science Foundation of Guangdong Province
  • Scientific Research Project of Hebei Provincial Administration of Traditional Chinese Medicine
  • The Young Top Talent of Science and Technology Innovation Department of Guangdong Province

Zitieren

APA

Qi, H., Ma, Q. H., Feng, W., Chen, S. M., Wu, C. S., Wang, Y., Wang, T. X., Hou, Y. L., & Jia, Z. H. (2024). Glycyrrhetinic acid blocks SARS‐CoV‐2 infection by activating the cGAS‐STING signalling pathway. British Journal of Pharmacology, 181(20), 3976-3992. https://doi.org/10.1111/bph.16473

Vancouver

Qi H, Ma QH, Feng W, Chen SM, Wu CS, Wang Y, et al. Glycyrrhetinic acid blocks SARS‐CoV‐2 infection by activating the cGAS‐STING signalling pathway. British Journal of Pharmacology. 2024;181(20):3976-3992. doi:10.1111/bph.16473

BibTeX
@article{Qi2024,
  author = {Qi, Hui and Ma, Qin-Hai and Feng, Wei and Chen, Si-Mian and Wu, Cai-Sheng and Wang, Yanan and Wang, Tong-Xing and Hou, Yun-Long and Jia, Zhen-Hua},
  title = {Glycyrrhetinic acid blocks SARS‐CoV‐2 infection by activating the cGAS‐STING signalling pathway},
  journal = {British Journal of Pharmacology},
  year = {2024},
  volume = {181},
  number = {20},
  pages = {3976--3992},
  doi = {10.1111/bph.16473}
}
Kostenlos starten →